IDEXX Announces Groundbreaking Cancer Dx Panel with Affordable Early Detection Test for Canine Lymphoma

Panel expansion planned over the next three years to cover the majority of canine cancer cases, transforming cancer detection and supporting earlier interventionWESTBROOK, Maine, Jan. 23, 2025 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced the launch of IDEXX Cancer Dx™, a first-of-its-kind diagnostic panel with early detection of lymphoma in dogs, especially the 20 million dogs at higher risk* for cancer in North America.1 IDEXX Cancer ...